APHB - AmpliPhi Biosciences Corporation

NYSE American - Nasdaq Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents8,1575,1325,7119,370
Short Term Investments----
Net Receivables---125
Inventory----
Other Current Assets----
Total Current Assets8,4085,3856,31310,016
Long Term Investments----
Property, plant and equipment5038161,0721,131
Goodwill---7,562
Intangible Assets2,9764,93710,76812,784
Accumulated Amortization----
Other Assets----
Deferred Long Term Asset Charges----
Total Assets11,88711,13818,15331,493
Current Liabilities
Accounts Payable7295781,0561,044
Short/Current Long Term Debt----
Other Current Liabilities383838613
Total Current Liabilities2,5721,9683,5382,385
Long Term Debt----
Other Liabilities8411,4394,8923,011
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities3,4133,4078,4305,396
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock323951659
Retained Earnings-406,316-394,206-381,360-362,522
Treasury Stock----
Capital Surplus414,467401,842391,067375,177
Other Stockholder Equity----
Total stockholders' equity8,4747,7319,72312,714
Net Tangible Assets5,4982,794-1,045-7,632